P.2.f.013 Clinical evidence for improvement in cognitive dysfunction in patients with major depressive disorder (MDD) after treatment with vortioxetine
Publication
, Conference
Keefe, RSE; Mahableshwarkar, AR; Olsen, CK
Published in: European Neuropsychopharmacology
October 2013
Duke Scholars
Published In
European Neuropsychopharmacology
DOI
ISSN
0924-977X
Publication Date
October 2013
Volume
23
Start / End Page
S402 / S403
Publisher
Elsevier BV
Related Subject Headings
- Psychiatry
- 5202 Biological psychology
- 3209 Neurosciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Keefe, R. S. E., Mahableshwarkar, A. R., & Olsen, C. K. (2013). P.2.f.013 Clinical evidence for improvement in cognitive dysfunction in patients with major depressive disorder (MDD) after treatment with vortioxetine. In European Neuropsychopharmacology (Vol. 23, pp. S402–S403). Elsevier BV. https://doi.org/10.1016/s0924-977x(13)70636-9
Keefe, R. S. E., A. R. Mahableshwarkar, and C. K. Olsen. “P.2.f.013 Clinical evidence for improvement in cognitive dysfunction in patients with major depressive disorder (MDD) after treatment with vortioxetine.” In European Neuropsychopharmacology, 23:S402–3. Elsevier BV, 2013. https://doi.org/10.1016/s0924-977x(13)70636-9.
Keefe RSE, Mahableshwarkar AR, Olsen CK. P.2.f.013 Clinical evidence for improvement in cognitive dysfunction in patients with major depressive disorder (MDD) after treatment with vortioxetine. In: European Neuropsychopharmacology. Elsevier BV; 2013. p. S402–3.
Keefe, R. S. E., et al. “P.2.f.013 Clinical evidence for improvement in cognitive dysfunction in patients with major depressive disorder (MDD) after treatment with vortioxetine.” European Neuropsychopharmacology, vol. 23, Elsevier BV, 2013, pp. S402–03. Crossref, doi:10.1016/s0924-977x(13)70636-9.
Keefe RSE, Mahableshwarkar AR, Olsen CK. P.2.f.013 Clinical evidence for improvement in cognitive dysfunction in patients with major depressive disorder (MDD) after treatment with vortioxetine. European Neuropsychopharmacology. Elsevier BV; 2013. p. S402–S403.
Published In
European Neuropsychopharmacology
DOI
ISSN
0924-977X
Publication Date
October 2013
Volume
23
Start / End Page
S402 / S403
Publisher
Elsevier BV
Related Subject Headings
- Psychiatry
- 5202 Biological psychology
- 3209 Neurosciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences